Cabazitaxel EP Impurity F

SZ目录编号:	SZ-C056089
CAS 号	NA
分子式	C53H63NO15
分子量	954.1
投资状态	Custom Synthesis

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new development or finding in product specification without further noticed.

化学名称: 5-[4-(Acetyloxy)-2α-(benzoyloxy)-1-hydroxy-7β,10β-dimethoxy-9-oxo-5β,20-epoxytax-11-en-13α-yl] 3-tert-butyl(2R,4S,5S)-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate (as per EP)

Shipping Temperature: Ambient

HSN Code: 38229010

Country of Origin: India

微笑: CC(O[C@]([C@@]1([H])C[C@H](OC)[C@]2(C([C@@H]3OC)=O)C)(CO1)[C@@]2([H])[C@@H]([C@]4(C(C)(C)C3=C(C)[C@@H](OC([C@]5([H])[C@H](C6=CC=CC=C6)N(C(OC(C)(C)C)=O)[C@@]([H])(C7=CC=C(OC)C=C7)O5)=O)C4)O)OC(C8=CC=CC=C8)=O)=O

Development and Validation of a Stability-indicating HPLC Method for the Analysis of Cabazitaxel in Jevtana Concentrate-solvent Leftover Samples
By Arnamo, Hedvig; Hillebrand, Michel J. X.; Huitema, Alwin D. R.; Nuijen, Bastiaan; Rosing, Hilde; Beijnen, Jos H.
From Current Pharmaceutical Analysis (2021), 17(6), 691-701

Development and Validation of a Stability-Indicating HPLC Method for the Determination of the Impurities in Cabazitaxel
By Li, Chengyan; Lan, Gongjian; Jiang, Jinyuan; Sun, Mingjie; Hang, Taijun
From Chromatographia (2015), 78(11-12), 825-831

Development and validation of a stability-indicating liquid chromatographic method for the assay of cabazitaxel
By Mathrusri Annapurna, M.; Venkatesh, B.; Pramadvara, K.; Hemchand, S.
From Chemical Science Transactions (2014), 3(2), 854-860, 7 pp.

Cabazitaxel EP Impurity F is chemically 5-[4-(Acetyloxy)-2α-(benzoyloxy)-1-hydroxy-7β,10β-dimethoxy-9-oxo-5β,20-epoxytax-11-en-13α-yl] 3-tert-butyl(2R,4S,5S)-2-(4-methoxyphenyl)-4-phenyl-1,3-oxazolidine-3,5-dicarboxylate (as per EP). Cabazitaxel EP Impurity F is supplied with detailed characterization data compliant with regulatory guideline. Cabazitaxel EP Impurity F can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Cabazitaxel.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.